Falco Holdings
4671.TTSE STANDARDServices
Filed as FALCO HOLDINGS Co., Ltd. (2022-06–2026-07)
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥43.6bn | ¥43.3bn | ¥43.0bn | ¥46.9bn | ¥50.0bn | ¥43.6bn |
| Operating income | ¥2.5bn | ¥2.3bn | ¥2.2bn | ¥3.1bn | ¥5.5bn | ¥2.6bn |
| Ordinary income | ¥2.7bn | ¥2.5bn | ¥2.3bn | ¥3.3bn | ¥5.8bn | ¥2.9bn |
| Net income (owners) | ¥2.0bn | ¥1.9bn | ¥1.7bn | ¥2.3bn | ¥3.5bn | ¥1.9bn |
| Total assets | ¥36.9bn | ¥36.0bn | ¥36.4bn | ¥38.9bn | ¥40.3bn | ¥37.1bn |
| Net assets / equity | ¥25.9bn | ¥25.3bn | ¥26.0bn | ¥26.6bn | ¥23.5bn | ¥20.5bn |
| Operating cash flow | ¥2.9bn | ¥2.6bn | ¥3.4bn | ¥2.1bn | ¥4.1bn | ¥2.9bn |
| EPS (basic) | ¥201.1 | ¥181.81 | ¥151.72 | ¥215.29 | ¥339 | ¥178.61 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 14
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2026-03-31 | AnnualAmended | 212 figures · EDINET |
| 2025-04-01 → 2026-03-31 | Annual | 212 figures · EDINET |
| 2025-04-01 → 2025-09-30 | Half-year | 74 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 212 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 74 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 212 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 52 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 76 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 50 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 212 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 52 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 76 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 50 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 212 figures · EDINET |
22 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| Clinical Testing Business | ¥26.7bn | ¥1.8bn |
| Dispensing Pharmacy Business | ¥15.2bn | ¥674m |
| ICT Business | ¥1.7bn | ¥458m |
| Adjustments & eliminations | — | −¥450m |
| Total | ¥43.6bn | ¥2.9bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.